이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

The Restorative Role of Daytime Naps in Mentally Fatigued Endurance Athletes (Nap&Run)

2026년 5월 5일 업데이트: Jacopo Vitale, L.U.de.S. Sagl

The Restorative Role of Daytime Naps in Mentally Fatigued Endurance Athletes: a Randomized Controlled Trial

This randomized, counterbalanced crossover study investigated whether a 30-minute daytime nap can mitigate the effects of experimentally induced mental fatigue in amateur master endurance athletes. Male athletes completed two home-based experimental sessions separated by one week: a mental fatigue condition, in which a 30-minute cognitively demanding task battery preceded the nap, and a control condition, in which participants took only the nap. Sleep parameters during the nap were monitored by wrist actigraphy, and perceived sleep quality was assessed after awakening. Subjective sleepiness, perceived mental fatigue, and cognitive performance were evaluated before the nap, immediately after the nap, and/or 30 minutes after the nap.

The study examined whether mental fatigue influenced nap characteristics and whether the nap improved recovery-related outcomes. The main outcomes included actigraphy-derived nap parameters, perceived sleep quality, sleepiness assessed with the Karolinska Sleepiness Scale, perceived mental fatigue assessed using a visual analogue scale, and cognitive performance assessed with a Flanker task.

연구 개요

연구 유형

중재적

등록 (실제)

11

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria:

  • Male amateur master endurance athletes
  • Age between 28 and 50 years
  • Peak oxygen uptake (VO₂peak) ≥55 mL·kg-¹·min-¹
  • Habitual nocturnal sleep duration of at least 7 hours
  • Able and willing to complete both experimental sessions and daytime nap procedures

Exclusion Criteria:

  • Diagnosed medical condition or injury
  • Diagnosed sleep disorder
  • Use of medications or supplements affecting sleep or cognition, including melatonin
  • Habitual sleep duration of less than 7 hours per night
  • Inability to nap during the experimental sessions

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Mental Fatigue + Daytime Nap
Participants completed a 30-minute mental fatigue induction protocol consisting of cognitively demanding tasks, followed by a 30-minute daytime nap performed at home between 14:00 and 15:00. Subjective sleepiness, perceived mental fatigue, nap characteristics, perceived sleep quality, and cognitive performance were assessed before and/or after the nap.
Participants completed a 30-minute computerized cognitive task battery designed to induce mental fatigue before the daytime nap. The protocol consisted of three consecutive 10-minute cognitively demanding tasks: a Flanker task, a memory task, and a Stroop task.
Participants took a 30-minute daytime nap at home between 14:00 and 15:00, at least one hour after lunch, in a quiet and dimly lit room. Nap characteristics were monitored using wrist actigraphy, and perceived sleep quality was assessed after awakening.
활성 비교기: Daytime Nap Control
Participants completed the control condition consisting of a 30-minute daytime nap performed at home between 14:00 and 15:00, without the preceding mental fatigue induction protocol. Subjective sleepiness, perceived mental fatigue, nap characteristics, perceived sleep quality, and cognitive performance were assessed before and/or after the nap.
Participants took a 30-minute daytime nap at home between 14:00 and 15:00, at least one hour after lunch, in a quiet and dimly lit room. Nap characteristics were monitored using wrist actigraphy, and perceived sleep quality was assessed after awakening.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Perceived mental fatigue
기간: Before the nap, immediately after the nap, and 30 minutes after the nap in each experimental condition.
Perceived mental fatigue was assessed using a 100-mm visual analogue scale for mental fatigue (VAS-MF), anchored from 0-mm "No mental fatigue" to 100-mm "Maximum mental fatigue." Participants marked the point that best represented their perceived level of mental fatigue.
Before the nap, immediately after the nap, and 30 minutes after the nap in each experimental condition.

2차 결과 측정

결과 측정
측정값 설명
기간
Subjective sleepiness
기간: Before the nap, immediately after the nap, and 30 minutes after the nap
Subjective sleepiness was assessed using the Karolinska Sleepiness Scale (KSS), a 9-point scale ranging from 1, "not sleepy at all," to 9, "extremely sleepy."
Before the nap, immediately after the nap, and 30 minutes after the nap
Flanker Task Reaction Time
기간: 30 minutes after the nap in each experimental condition.
Accuracy during the computerized Flanker task was calculated as the percentage of correct responses and used as an indicator of executive function performance. Accuracy ranges from 0 to 100%.
30 minutes after the nap in each experimental condition.
Perceived Nap Sleep Quality
기간: Immediately after the nap in each experimental condition.
Perceived sleep quality after the nap was assessed using a 10-point Likert scale, from 0 to 10, with higher scores indicating better perceived sleep quality.
Immediately after the nap in each experimental condition.
Actigraphy-Derived nap start time
기간: During the 30-minute daytime nap in each experimental condition.
Clock time at which the nap period begins, usually identified from the rest interval or sleep diary. Nap start time is expressed as clock time, using the 24-hour format.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap time in bed
기간: During the 30-minute daytime nap in each experimental condition.
Total time spent in bed or within the defined nap/rest interval, from nap start time to nap end time. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap total sleep time
기간: During the 30-minute daytime nap in each experimental condition.
Total duration of epochs scored as sleep during the nap/rest interval. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap sleep onset latency
기간: During the 30-minute daytime nap in each experimental condition.
Time elapsed between nap start time and the first epoch scored as sleep. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap sleep efficiency
기간: During the 30-minute daytime nap in each experimental condition.
Sleep efficiency is expressed as a percentage, ranging from 0% to 100%, and is calculated as the ratio between total sleep time and time in bed multiplied by 100
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap fragmentation index
기간: During the 30-minute daytime nap in each experimental condition.
An index reflecting sleep disruption or restlessness, based on movement and short immobility bouts during the sleep period. Higher values indicate more fragmented sleep. Fragmentation index is expressed as a percentage from 0% to 100%
During the 30-minute daytime nap in each experimental condition.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2021년 1월 11일

기본 완료 (실제)

2021년 5월 15일

연구 완료 (실제)

2021년 5월 15일

연구 등록 날짜

최초 제출

2026년 4월 28일

QC 기준을 충족하는 최초 제출

2026년 5월 5일

처음 게시됨 (실제)

2026년 5월 12일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 5월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 5월 5일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data will not be made publicly available. Data supporting the findings of this study may be available from the corresponding author upon reasonable request.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다